Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 18 years and younger than 80 years
- People who have had persistent atrial fibrillation (an irregular heart rhythm) lasting more than 1 year
- People whose left atrium (a chamber of the heart) measures less than 6cm in size
- People who are able to sign a written consent form agreeing to take part
Who may not be able to join:
- People who are currently taking part in another research study involving a treatment or intervention (participation in an observation-only registry with no treatment may be acceptable — confirm with trial site)
- People whose atrial fibrillation has a reversible or temporary cause
- People who were born without a left atrial appendage (a small pouch in the heart), or who have previously had that pouch surgically closed off
- People who have previously had heart surgery or abdominal (stomach area) surgery
- People who are unable to take blood-thinning medication (anticoagulants) for medical reasons
- People who have a condition called hypertrophic cardiomyopathy (a thickened heart muscle)
- People who have significant disease affecting their heart valves
- People who have previously had a procedure (either catheter-based or surgical) to treat their irregular heart rhythm
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Syed Ahsan, Consultant Cardiologist and Electrophysiologist, Barts Health NHS Trust
Phone: 020 7377 7000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Demonstrate trial feasibility with regards to recruitment rate; A composite of major adverse events (MAE) and complications occurring within 30 days post procedure will be measured.; Success or failure at 12 months of persistent AF patients to be free of: Atrial arrhythmia (classed as documentation of atrial fibrillation, atrial flutter or atrial tachycardia lasting for more than 30 seconds); Measure improvement in symptoms following convergent ablation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.